Top 10 Parkinson’s Disease Stories of 2021
All through 2021, Parkinson’s News Today brought you coverage of cutting-edge science and developments in treatment related to Parkinson’s disease.
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
All through 2021, Parkinson’s News Today brought you coverage of cutting-edge science and developments in treatment related to Parkinson’s disease.
In a “world-first,” scientists in Australia report in detail what happens to the PINK1 protein when it is activated, helping…
In the United States, the prevalence of Parkinson’s disease is higher in states with more lead pipes that carry…
People with Parkinson’s disease tend to have high numbers of pro-inflammatory bacteria in their noses, according to a new…
More people with Parkinson’s disease than previously estimated experience pseudobulbar affect, and its emotional outbursts can be especially common…
Gout does not increase the risk of developing Parkinson’s disease, according to an analysis based on insurance data in…
Although some previous research has indicated that certain variations in the FGF20 gene increase the risk of Parkinson’s disease,…
A new clinical trial is testing a novel noninvasive brain stimulation technology developed by Highland Instruments in people with…
Nearly all participants in the SPARK clinical trial had evidence of abnormal dopamine activity on a brain scan known as…
The Parkinson’s Progression Markers Initiative (PPMI) is expanding to enroll up to 100,000 people with and without Parkinson’s disease…
Get regular updates to your inbox.